Plaintiffs allege that Yasmin drug causes blood clots

This blog has reported on pharmaceutical companies that have had lawsuits filed against them for releasing products that harm their consumers. Bayer has found itself in this position when customers began accusing the company of developing a birth control drug called Yasmin that has allegedly  caused blood clots in many women.

Bayer, which is based in Germany, settled U.S. lawsuits by providing more than $402 million to plaintiffs. This will likely be divided into $212,000 for each case, according to Bloomberg Businessweek. More than 1,900 cases were brought against Bayer, in which plaintiffs alleged that Yasmin caused blood clots and increased women's risk of heart attacks and stroke.

"We believe we have made appropriate provisions for most of the cases we consider to be worthy of settlement with these accounting measures," Bayer said in a statement.

According to Albany, New York newspaper The Times Union, Angela Wright allegedly developed a blood clot from Yasmin as well as deep vein thrombosis and pulmonary embolism.

In April of 2012, the Food and Drug Administration issued a new review on the Yasmin birth control pill and concluded that the medication may have a higher risk of blood clots than other progestin-containing oral contraceptives.

The Pharma Times, an online publication, reported that the net income for Bayer decreased by 33.9 percent in the second quarter of 2012. After the widely-publicized lawsuits hit, sales among its products fell by 6.4 percent.

Companies around the country that wish to protect their assets and ensure that their products follow appropriate safety regulations should consider partnering with a Phoenix business law firm, which can outline appropriate precautions to take.

Categorised in: Uncategorized

This post was written by